Femasys FEMY
NASDAQ FEMY
$2.83 +0.15 (+5.60%)
At close: Sep 9, 2026 · 4:00 PM EDT

Femasys (FEMY) Research & Development (2020 - 2026)

Femasys' (FEMY) quarterly Research & Development came in at $1.9 million in Q2 2026, up 37.64% on a YoY basis from $1.4 million in Q2 2025, and up 37.64% quarter-over-quarter from $1.4 million in Q2 2025.

Analysis

Femasys (FEMY) Research & Development (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Research & Development for 7 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development rose 37.64% year-over-year to $1.9 million; the trailing twelve-month figure through Jun 2026 stood at $8.5 million (down 4.03% YoY), and the FY2025 full-year result was $7.6 million, down 7.78% from the prior year.
  • Research & Development grew to $1.9 million in Q2 2026 per FEMY's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $3.0 million in Q1 2025 and bottomed at $1.3 million in Q4 2022.
  • Historically, Research & Development has averaged $1.8 million across 5 years, with a median of $1.8 million in 2024.
  • The widest YoY moves for Research & Development: up 67.64% in 2025, down 28.42% in 2025.
  • Over 5 years, Research & Development stood at $1.3 million in 2022, then surged by 62.89% to $2.1 million in 2023, then grew by 4.61% to $2.2 million in 2024, then slumped by 34.72% to $1.4 million in 2025, then soared by 37.64% to $1.9 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $1.9 million, $1.4 million, and $3.0 million for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 892.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 370.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 771.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 434.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 554.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 278.90 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -663.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 153.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 28.60 Mn
10 Femasys 9.37 Mn 7.92 Mn 189,391.00 1.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.95 Mn
Jun 30, 2025 1.41 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 2.17 Mn
Sep 30, 2024 2.30 Mn
Jun 30, 2024 1.98 Mn
Mar 31, 2024 1.77 Mn
Dec 31, 2023 2.07 Mn
Sep 30, 2023 2.07 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 1.54 Mn
Dec 31, 2022 1.27 Mn
Sep 30, 2022 1.65 Mn
Jun 30, 2022 1.47 Mn
Mar 31, 2022 1.42 Mn
Dec 31, 2021 1.05 Mn
Sep 30, 2021 1.14 Mn
Jun 30, 2021 894,868.00
Mar 31, 2021 995,022.00
Dec 31, 2020 895,591.00